XERS - Xeris gains as Oppenheimer highlights drug technology
2024-03-28 13:11:15 ET
More on Xeris Pharmaceuticals
- Xeris Biopharma (XERS) Q4 2023 Earnings Call Transcript
- Xeris Biopharma: Speculative Buy, Size Your Position Accordingly
- Xeris Biopharma Holdings Stock Is A Hold With Robust Performance Into 2024
- Xeris Pharmaceuticals Q4 2023 Earnings Preview
- Amgen in pact with Xeris Biopharma for Tepezza injectable